Literature DB >> 16199121

New drug prescribing by hospital doctors: the nature and meaning of knowledge.

Helen Prosser1, Tom Walley.   

Abstract

In the UK the high cost of new drugs is partly accountable for the growth in spending on prescription drugs. Most prescribing takes place in general practice and the influence of secondary care prescribing on primary care prescribing is well recognized; yet the factors that influence hospital prescribing have been little researched. Drawing on accounts of actual prescribing events from hospital doctors from a range of specialties, we investigated the processes by which new drugs come into practice, from hospital doctors' awareness of new drugs to the assimilation and interpretation of evidential sources. The determinants of new drug prescribing were interconnected within four forms of knowledge: scientific knowledge, social knowledge, patient knowledge and experiential knowledge. Furthermore, the nature of knowledge could only be understood within its situated context. The revelation of multiple and contingent forms of knowledge highlights the problematic nature of knowledge construction within the approaches of evidence-based medicine.

Entities:  

Mesh:

Year:  2005        PMID: 16199121     DOI: 10.1016/j.socscimed.2005.08.035

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  14 in total

1.  Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study.

Authors:  Viktorija Erdeljic; Igor Francetic; Viola Macolic Sarinic; Marinko Bilusic; Ksenija Makar Ausperger; Mirjana Huic; Iveta Mercep
Journal:  Pharm World Sci       Date:  2006-11-17

2.  Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people.

Authors:  Syed Imran Haider; Kristina Johnell; Gunilla Ringbäck Weitoft; Mats Thorslund; Johan Fastbom
Journal:  Eur J Clin Pharmacol       Date:  2008-08-10       Impact factor: 2.953

3.  Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015.

Authors:  Kari R Gillmeyer; Seppo T Rinne; Mark E Glickman; Kyung Min Lee; Qing Shao; Shirley X Qian; Elizabeth S Klings; Bradley A Maron; Joseph T Hanlon; Donald R Miller; Renda Soylemez Wiener
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-05-12

4.  Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care.

Authors:  Sammuel V Anderegg; David E Demik; Barry L Carter; Jeffrey D Dawson; Karen Farris; Constance Shelsky; Peter Kaboli
Journal:  Pharmacotherapy       Date:  2013-01       Impact factor: 4.705

5.  Descriptive Analysis of Acceptance by Prescribers and Economic Benefit of Pharmacist Recommended Interventions in a Critical Care Unit.

Authors:  YoonJung Lee; Lana Gettman
Journal:  Innov Pharm       Date:  2018-07-19

6.  Nation-scale adoption of new medicines by doctors: an application of the Bass diffusion model.

Authors:  Adam G Dunn; Jeffrey Braithwaite; Blanca Gallego; Richard O Day; William Runciman; Enrico Coiera
Journal:  BMC Health Serv Res       Date:  2012-08-10       Impact factor: 2.655

7.  Quality and quantity of information in summary basis of decision documents issued by health Canada.

Authors:  Roojin Habibi; Joel Lexchin
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

8.  Factors influencing rheumatologists' prescription of biological treatment in rheumatoid arthritis: an interview study.

Authors:  Almina Kalkan; Kerstin Roback; Eva Hallert; Per Carlsson
Journal:  Implement Sci       Date:  2014-10-11       Impact factor: 7.327

Review 9.  Factors affecting the uptake of new medicines: a systematic literature review.

Authors:  Ágnes Lublóy
Journal:  BMC Health Serv Res       Date:  2014-10-20       Impact factor: 2.655

10.  Counseling customers: emerging roles for genetic counselors in the direct-to-consumer genetic testing market.

Authors:  Anna Harris; Susan E Kelly; Sally Wyatt
Journal:  J Genet Couns       Date:  2012-10-25       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.